{"id":"https://openalex.org/W2248762046","doi":"https://doi.org/10.1200/jco.2010.28.15_suppl.2095","title":"A clinical study investigating MPC-6827 with carboplatin in the treatment of patients with relapsed glioblastoma multiforme.","display_name":"A clinical study investigating MPC-6827 with carboplatin in the treatment of patients with relapsed glioblastoma multiforme.","publication_year":2010,"publication_date":"2010-05-20","ids":{"openalex":"https://openalex.org/W2248762046","doi":"https://doi.org/10.1200/jco.2010.28.15_suppl.2095","mag":"2248762046"},"language":"en","primary_location":{"id":"doi:10.1200/jco.2010.28.15_suppl.2095","doi":"https://doi.org/10.1200/jco.2010.28.15_suppl.2095","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2010.28.15_suppl.2095","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5073549408","display_name":"Kenneth F. Grossmann","orcid":"https://orcid.org/0000-0002-8523-7407","observed_orcids":["https://orcid.org/0000-0002-8523-7407"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"K. F. Grossmann","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":null,"display_name":"J. H. Ward","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"J. H. Ward","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5016686763","display_name":"Wallace Akerley","orcid":"https://orcid.org/0000-0002-3090-4778","observed_orcids":["https://orcid.org/0000-0002-3090-4778"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"W. L. Akerley","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5070567202","display_name":"Michael Glantz","orcid":"https://orcid.org/0000-0003-4877-5094","observed_orcids":["https://orcid.org/0000-0003-4877-5094"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"M. J. Glantz","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5055183757","display_name":"John de Groot","orcid":"https://orcid.org/0000-0003-1454-6461","observed_orcids":["https://orcid.org/0000-0003-1454-6461"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"J. F. De Groot","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5067646281","display_name":"Robert D. Aiken","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"R. Aiken","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5061676019","display_name":"Jeffrey J. Olson","orcid":"https://orcid.org/0000-0002-9968-681X","observed_orcids":["https://orcid.org/0000-0002-9968-681X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"J. J. Olson","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":null,"display_name":"Y. Matsuoka","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Y. Matsuoka","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103094893","display_name":"Margaret K. Yu","orcid":"https://orcid.org/0009-0003-1697-3595","observed_orcids":["https://orcid.org/0009-0003-1697-3595","https://orcid.org/0000-0002-3650-2788"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"M. K. Yu","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5080895084","display_name":"Randy L. Jensen","orcid":"https://orcid.org/0000-0002-2824-4221","observed_orcids":["https://orcid.org/0000-0002-2824-4221"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"R. L. Jensen","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":1,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"28","issue":"15_suppl","first_page":"2095","last_page":"2095"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10129","display_name":"Glioma Diagnosis and Treatment","score":0.9940999746322632,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10129","display_name":"Glioma Diagnosis and Treatment","score":0.9940999746322632,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10422","display_name":"Angiogenesis and VEGF in Cancer","score":0.00039999998989515007,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10550","display_name":"Ovarian cancer diagnosis and treatment","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/carboplatin","display_name":"carboplatin","score":0.9580000042915344},{"id":"https://openalex.org/keywords/microtubule-destabilizing-agents","display_name":"microtubule destabilizing agents","score":0.871999979019165},{"id":"https://openalex.org/keywords/combination-chemotherapy","display_name":"combination chemotherapy","score":0.640999972820282},{"id":"https://openalex.org/keywords/dose-limiting-toxicity","display_name":"dose-limiting toxicity","score":0.9179999828338623},{"id":"https://openalex.org/keywords/thrombocytopenia","display_name":"thrombocytopenia","score":0.8640000224113464},{"id":"https://openalex.org/keywords/transient-ischemic-attack","display_name":"transient ischemic attack","score":0.9399999976158142},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.8899999856948853},{"id":"https://openalex.org/keywords/brain-penetration","display_name":"brain penetration","score":0.4359999895095825},{"id":"https://openalex.org/keywords/safety-and-tolerability","display_name":"safety and tolerability","score":0.675000011920929}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9529852271080017},{"id":"https://openalex.org/C2781451048","wikidata":"https://www.wikidata.org/wiki/Q415588","display_name":"Carboplatin","level":4,"score":0.8450162410736084},{"id":"https://openalex.org/C2778375690","wikidata":"https://www.wikidata.org/wiki/Q7814214","display_name":"Tolerability","level":3,"score":0.7666512727737427},{"id":"https://openalex.org/C2781413609","wikidata":"https://www.wikidata.org/wiki/Q7308373","display_name":"Regimen","level":2,"score":0.5997388362884521},{"id":"https://openalex.org/C72563966","wikidata":"https://www.wikidata.org/wiki/Q1303415","display_name":"Cohort","level":2,"score":0.5571147799491882},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5483579635620117},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.4814283549785614},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.4566653370857239},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.36358314752578735},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.33364802598953247},{"id":"https://openalex.org/C2778239845","wikidata":"https://www.wikidata.org/wiki/Q412415","display_name":"Cisplatin","level":3,"score":0.058410704135894775}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1200/jco.2010.28.15_suppl.2095","doi":"https://doi.org/10.1200/jco.2010.28.15_suppl.2095","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2010.28.15_suppl.2095","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":1.0,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2248747155","https://openalex.org/W2114237537","https://openalex.org/W2168851204","https://openalex.org/W2591248049","https://openalex.org/W2330361544","https://openalex.org/W2966045481","https://openalex.org/W2507200596","https://openalex.org/W1065125636","https://openalex.org/W1478765522","https://openalex.org/W4416140974"],"abstract_inverted_index":{"2095":[0],"Background:":[1],"MPC-6827":[2,15,30,41,56,101,208,267,323],"(Azixa;":[3],"4-arylaminoquinazoline)":[4],"is":[5,317,334],"a":[6,50,60,67,184,203,251,276,344],"microtubule":[7],"destabilizing":[8],"agent":[9],"that":[10],"achieves":[11],"high":[12],"brain":[13],"concentrations.":[14],"disrupts":[16],"newly":[17],"formed":[18],"blood":[19],"vessels":[20],"in":[21,32,49,71,81,164,171,250,279,329],"xenografts.":[22],"We":[23],"determined":[24],"the":[25,72,95,115,136,172,196,228,235,256],"safety":[26],"and":[27,46,121,221,233,239,285,336],"tolerability":[28],"of":[29,40,66,79,100,109,145,158,266,322,350],"administered":[31,86],"combination":[33,321],"with":[34,327,331,343],"carboplatin.":[35],"Methods:":[36],"Three":[37,199],"preselected":[38],"doses":[39],"were":[42,130,141,169],"tested:":[43],"2.1,":[44],"2.7,":[45],"3.3":[47,122,229,325],"mg/m2":[48,74,99,117,123,230,326],"standard":[51],"\u201c3":[52],"+":[53],"3\u201d":[54],"design.":[55],"was":[57,85,234,268,308],"given":[58],"as":[59],"2-hr":[61],"IV":[62,87],"infusion":[63],"every":[64,91,257],"2":[65,92,258],"6":[68,294],"wk":[69,112,259],"cycle":[70,113],"2.1":[73,98],"cohort":[75,96],"or":[76,105,166,206,209,359,363],"3":[77,205],"wks":[78,93],"4":[80,90,111,247],"subsequent":[82],"cohorts.":[83],"Carboplatin":[84],"at":[88,227,241,286,324],"AUC":[89],"for":[94,114,132],"receiving":[97,253],"(n":[102,118,126],"=":[103,119,127],"8)":[104],"on":[106,255],"Day":[107],"1":[108],"each":[110],"2.7":[116],"3)":[120],"dose":[124,231,243],"levels":[125],"8).":[128],"Patients":[129],"observed":[131],"acute":[133],"DLTs":[134],"during":[135],"first":[137,165],"cycle.":[138],"PK":[139],"evaluations":[140],"performed.":[142],"Results:":[143],"As":[144],"December":[146],"7,":[147],"2009,":[148],"19":[149],"patients":[150,175,181,192,200,295,330],"(median":[151],"age,":[152],"51,":[153],"range,":[154],"21-75;":[155],"median":[156,262,304],"number":[157],"prior":[159],"therapies,":[160],"2,":[161],"range":[162,300],"1-4)":[163],"second":[167],"relapse":[168],"enrolled":[170],"study.":[173],"Fourteen":[174],"(74%)":[176],"had":[177,183,193],"one":[178],"lesion.":[179],"Sixteen":[180],"(95%)":[182],"Karnofsky":[185],"performance":[186],"score":[187],"greater":[188,207],"than":[189],"70.":[190],"All":[191],"previously":[194],"received":[195],"Stupp":[197],"regimen.":[198],"(15.7%)":[201],"experienced":[202],"grade":[204,246],"carboplatin-related":[210],"adverse":[211],"event,":[212],"including":[213],"pyrexia":[214],"(5.3%),":[215,220],"transient":[216],"ischemic":[217],"attack":[218],"(TIA)":[219],"thrombocytopenia":[222,248],"(5.3%).":[223],"The":[224,245,261,303,320],"TIA":[225],"occurred":[226,249],"level":[232],"only":[236],"MPC-6827-related":[237],"SAE":[238],"DLT":[240],"this":[242,280,340],"level.":[244],"patient":[252,341],"carboplatin":[254,328],"schedule.":[260],"plasma":[263],"half":[264],"life":[265],"3.22":[269],"hrs":[270],"(range":[271],"2.04-9.03).":[272],"Two":[273],"subjects":[274],"achieved":[275,296],"partial":[277],"response":[278],"study":[281],"(duration":[282,299],"7.5":[283],"mos":[284,310],"least":[287],"4.3":[288],"mos)":[289],"by":[290],"Macdonald":[291],"criteria.":[292],"Another":[293],"stable":[297],"disease":[298],"1\u20137":[301],"mos).":[302],"progression-free":[305],"survival":[306],"time":[307],"1.8":[309],"(95%":[311],"CI:":[312],"[1.3,":[313],"7.1]).":[314],"Data":[315],"collection":[316],"ongoing.":[318],"Conclusions:":[319],"recurrent/refractory":[332],"GBM":[333],"safe":[335],"well":[337],"tolerated.":[338],"In":[339],"population":[342],"highly":[345],"vascularized":[346],"tumor,":[347],"no":[348],"incidence":[349],"cerebral":[351],"hemorrhage":[352],"has":[353],"been":[354],"reported.":[355],"Author":[356],"Disclosure":[357],"Employment":[358],"Leadership":[360],"Position":[361],"Consultant":[362],"Advisory":[364],"Role":[365],"Stock":[366],"Ownership":[367],"Honoraria":[368],"Research":[369],"Funding":[370],"Expert":[371],"Testimony":[372],"Other":[373],"Remuneration":[374],"Myriad":[375,377,379],"Pharmaceuticals":[376,378,380]},"counts_by_year":[{"year":2012,"cited_by_count":1}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}